Pre-eclampsia - risk estimation - serum
Back to main menuEurofins Biomnis code
PECLA
Synonyms
- Pre-eclampsia
- PIGF
- Pre-eclampsia risk calculation
Clinic significance
PlGF (Placental Growth Factor) is, together with PAPP-A, a biochemical marker for pre-eclampsia. Assays are performed during the first trimester of pregnancy. It is possible to calculate an risk of early-onset (before 34 weeks of gestation) or late-onset pre-eclampsia (before 37 SA). This calculation of risk includes data about the patient (BMI, smoker/non-smoker, geographic origin, etc.) the history (number of viable pregnancies, history of pre-eclampsia, hypertension) and pregnancy underway (dating: date of the ultrasound and craniocaudal length) in addition to blood pressure and Doppler of uterine arteries.
Prenalytics
- 3 mL
- Serum (1 specific tube for pre-eclampsia screening)
- Refrigerated
Further information
- Sample must be collected between 11.0 and 13.6 weeks of amenorrhoea
- Arterial blood pressure should be taken on both arms at the same time; if not, a single arm will suffice.
The period between the ultrasound scan, the taking of blood pressure and sample collection
must not exceed 10 days. - Risk assessment is possible for monofoetal pregnancies only
- Enclose the specific clinical information form (R4-INTGB: Pre-eclampsia)
- Non hemolysed, non-icteric, non lipemic sample. Sample must be centrifuged as quickly as possible and international samples must be frozen within 4 hours of sampling; except for Switzerland, Luxembourg and Belgium (REFRIGERATED)
Please conserve an additional sample in your serolibrary until you have received the result.
Specific equipment available
[To be translated]
Documents to download
Methodology
Fluoro-Immunoassay (time resolved)
Turnaround time
1 week
Pathologist(s) in charge
Biomnis Lyon
Specialty
Down Syndrome screening and foetal biochemistry
Contact(s)
Dr Corinne SAULT
Dr Alain LIQUIER
Dr Alain LIQUIER
Phone(s)
+334 72 80 73 75
+334 72 80 23 61
+334 72 80 23 61